Trial Profile
The effect of DPP-4 inhibitor on pancreatic beta cell function and renal function in type 2 diabetic patients
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Glimepiride (Primary) ; Sitagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms K-SPIRIT
- 04 Sep 2012 New trial record